Dr. Nohria is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St
Pbb-1, Room 364
Boston, MA 02115Phone+1 617-525-7052Fax+1 617-264-5265- Is this information wrong?
Education & Training
- Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1998 - 2001
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1994 - 1997
- Harvard Medical SchoolClass of 1994
Certifications & Licensure
- FL State Medical License 2022 - 2026
- MA State Medical License 2000 - 2025
- NH State Medical License 2022 - 2024
- RI State Medical License 2022 - 2024
- ME State Medical License 2011 - 2024
- CT State Medical License 1997 - 1998
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction Start of enrollment: 2003 Apr 01
- Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis Start of enrollment: 2008 Mar 13
- Inflammation and Vascular Function in Atherosclerosis Start of enrollment: 2005 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Ischaemic heart disease in patients with cancer.Pietro Ameri, Edoardo Bertero, Marco Lombardi, Italo Porto, Marco Canepa, Anju Nohria, Rocco Vergallo, Alexander R Lyon, Teresa López-Fernández> ;European Heart Journal. 2024 Feb 7
- Association of N-terminal Pro-Brain natriuretic peptide with survival among US cancer survivors.Cao, C., Yang, L., Nohria, A., Mayer, E., Partridge, A., Ligibel, J.> ;Journal of the National Cancer Institute. 2024 Feb 1
- 1 citationsSevere vs Nonsevere Immune Checkpoint Inhibitor-Induced Myocarditis: Contemporary 1-Year Outcomes.Itzhaki Ben Zadok, O., Levi, A., Divakaran, S., Nohria, A.> ;JACC. Cardiooncology. 2023 Dec 1
- Join now to see all
Authored Content
- Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir in Patients with COVID-19: JACC Review Topic of the WeekOctober 2022
Press Mentions
- Research Letter Myocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint InhibitorsMarch 16th, 2021
- Development and Implementation of an Online Adaptive SBRT Workflow for Treatment of Intracardiac MetastasisFebruary 5th, 2021
- Screenings for Cardiac Dysfunction Among Childhood Cancer Survivors Can Be More Precisely TailoredAugust 15th, 2020
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
- Maine Medical CenterPortland, Maine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: